Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 192,640 | 254,382 | 268,682 | 248,168 | 227,188 |
| Cost of Goods | 14,796 | 24,282 | 25,629 | 23,364 | 24,488 |
| Gross Profit | 177,844 | 230,100 | 243,053 | 224,804 | 202,700 |
| Operating Expenses | 192,592 | 224,053 | 201,517 | 197,929 | 180,378 |
| Operating Income | -13,952 | 6,329 | 42,165 | 27,239 | 22,810 |
| Other Income | 20,291 | 4,971 | 199 | 4,416 | 6,218 |
| Pre-tax Income | 6,339 | 11,300 | 42,364 | 31,655 | 29,028 |
| Income Tax | 3,830 | 5,025 | 9,212 | 8,318 | -86,525 |
| Net Income Continuous | 2,509 | 6,275 | 33,152 | 23,337 | 115,553 |
| Net Income | $2,509 | $6,275 | $33,152 | $23,337 | $115,553 |
| EPS Basic Total Ops | 0.04 | 0.11 | 0.60 | 0.43 | 2.17 |
| EPS Basic Continuous Ops | 0.04 | 0.11 | 0.60 | 0.43 | 2.17 |
| EPS Diluted Total Ops | 0.04 | 0.11 | 0.58 | 0.42 | 2.11 |
| EPS Diluted Continuous Ops | 0.04 | 0.11 | 0.58 | 0.42 | 2.11 |
| EPS Diluted Before Non-Recurring Items | 0.04 | 0.11 | 0.58 | 0.42 | 2.11 |
| EBITDA(a) | $-19,741 | $6,099 | $46,655 | $30,282 | $22,603 |